[Treatment of New Daily Persistent Headache With Esketamine: Report of One Case].
Li Zhang, Jiao He, Cheng-Hui Pi, Ming-Jie Zhang, Zhao Dong
Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae August 1, 2024 DOI: 10.3881/j.issn.1000-503X.15842 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | Patient with refractory new daily persistent headache |
| Intervention | Esketamine |
| Dose | sub-anesthetic dose |
| Topics | Esketamine |
| Keywords | Deep brain stimulation Headache therapy Headache management Esketamine ketamine Ketamine therapy Intractable pain Brain disorders Medical |
| Citations | 1 |
| Key findings | Intravenous esketamine at a sub-anesthetic dose was used to treat a case of refractory new daily persistent headache. |
Abstract
New daily persistent headache (NDPH) is a kind of persistent headache that patients can identify the exact date of the sudden onset.It is one of the rare primary headaches difficult to be cured and may lead to disability,seriously affecting the daily life and work.The exact pathogenesis of NDPH remains unclear,which makes the treatment difficult.Here we report a case of refractory NDPH treated by intravenous injection of esketamine at a sub-anesthetic dose.
Comparable studies
Other case reports and case series on esketamine, most cited first.